Evidence map›Paper›PMID 28855579›Full record

ArticleScientific reports2017

Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice.

Yasutomo Imai, Yuka Hosotani, Hiroto Ishikawa, Koubun Yasuda, Makoto Nagai, Orie Jitsukawa, Fumi Gomi, Kenji Nakanishi, Tomohiro Yoshimoto, Takahiro Nakamura and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. ILCs and Allergy.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yasutomo ImaiDepartment of Dermatology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.ORCID 0000-0003-3169-5717
Yuka HosotaniDepartment of Ophthalmology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.
Hiroto IshikawaDepartment of Ophthalmology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.
Koubun YasudaDepartment of Immunology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.
Makoto NagaiDepartment of Dermatology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.
Orie JitsukawaDepartment of Dermatology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.
Fumi GomiDepartment of Ophthalmology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.ORCID 0000-0003-0807-8817
Kenji NakanishiDepartment of Immunology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.ORCID 0000-0002-8988-1726
Tomohiro YoshimotoDepartment of Immunology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan.ORCID 0000-0002-4523-114X
Takahiro NakamuraDepartment of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kamigyo-ku, 602-0841, Kyoto, Japan.
Kiyofumi YamanishiDepartment of Dermatology, Hyogo College of Medicine, Nishinomiya, 663-8501, Hyogo, Japan. kyamanis@hyo-med.ac.jp.ORCID 0000-0003-0484-2320
Hyogo Medical University · JPKyoto Prefectural University of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a transgenic mouse line hK14mIL33tg, with the expression of interleukin-33 (IL-33) driven by a keratin 14 promoter, keratoconjunctivitis developed spontaneously between 18 and 22 weeks of age under specific-pathogen-free conditions. These mice showed blepharitis and corneal impairments, and the histology revealed epithelial thickening in the conjunctiva and the cornea with infiltration of eosinophils, mast cells and basophils. IL-5, IL-13 and CCL11 were abundant in lacrimal fluid in the mice, and the gene expressions of IL-4, IL-5, IL-13, IL-33, Prg2 and Mmcp8 were significantly increased in the cornea. Furthermore, group 2 innate lymphoid cells (ILC2) producing IL-5 and IL-13 were markedly increased in the cornea. These phenotypes closely resemble human atopic keratoconjunctivitis (AKC). The characteristic ocular phenotype in these mice strongly suggests that IL-33 is crucial for the development of AKC. The mouse line may be useful as a novel model for research and development of therapeutic strategies for AKC.

Indexed as

Disease Models, AnimalFounder EffectAnimalsBasophilsChemokine CCL11ConjunctivaEosinophilsEpithelium, CornealGene Expression RegulationImmunity, InnateInterleukin-13Interleukin-33Interleukin-4Interleukin-5Keratin-14KeratoconjunctivitisCcl11 protein, mouseChemokine CCL11Il33 protein, mouseInterleukin-13Interleukin-33Interleukin-4Interleukin-5Keratin-14Krt14 protein, mouseMcpt8 protein, mouseMembrane ProteinsPrg-2 protein, mouseTryptases

Identifiers

PMID28855579
PMCPMC5577277
OpenAlexW2746984865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.